Core Viewpoint - The Gross Law Firm is notifying shareholders of Perrigo Company plc regarding a class action lawsuit due to alleged misleading statements and operational deficiencies related to the company's infant formula business [1][3]. Group 1: Allegations - The complaint alleges that during the class period from February 27, 2023, to November 4, 2025, Perrigo issued materially false and misleading statements [3]. - Specific allegations include significant underinvestment in the infant formula business acquired from Nestlé, necessitating substantial capital and operational expenditures beyond stated cost estimates [3]. - The complaint also highlights significant manufacturing deficiencies in the infant formula facility, leading to overstated financial results, including earnings and cash flow [3]. Group 2: Class Action Details - Shareholders who purchased PRGO shares during the specified class period are encouraged to register for the class action, with a deadline of January 16, 2026, to seek lead plaintiff status [4]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's progress [4]. - Participation in the case incurs no cost or obligation for shareholders [4]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors affected by misleading statements that inflate stock prices [5].

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP reminds investors its investigation on behalf of Ardent Health, Inc. ("Ardent†or the "Company†) (NYSE:ARDT) investors concerning the Company's and/or members of its senior management's possible violation of the federal securities laws or other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On November 12, 2025, Ardent issued a press release announcing its financial results for the third quarter of. ...

Core Viewpoint - The company Alexandria Real Estate Equities is facing legal action due to allegations of violating federal securities laws by making misleading statements regarding its Long Island City property and its leasing value as part of its Megacampus strategy [2]. Financial Performance - Alexandria reported third quarter earnings for 2025 that did not meet analyst expectations, with a 5% decline in revenue and a 7% decline in adjusted funds from operation [3]. - The average occupancy rate for Alexandria decreased from 94.8% in the previous year to 91.4% [3]. - Following the release of these financial results, Alexandria's stock price dropped over 19% on October 28, 2025 [3]. Legal Proceedings - A lead plaintiff has been appointed in the class action lawsuit, representing the investor with the largest financial interest in the case [4]. - Any member of the putative class can move to serve as lead plaintiff or choose to remain an absent class member without affecting their ability to share in any recovery [4]. Whistleblower Information - The law firm Faruqi & Faruqi encourages individuals with information regarding Alexandria's conduct, including whistleblowers and former employees, to come forward [5].

Core Viewpoint - Kirby McInerney LLP is investigating Car-Mart, Inc. for potential violations of federal securities laws and other unlawful business practices by the company and/or its senior management [1] Group 1: Investigation Details - The investigation is focused on Car-Mart, Inc. (NASDAQ: CRMT) and its senior management's possible legal violations [1] - On July 15, 2025, Car-Mart announced a delay in filing its annual report due to management identifying the need for further review [1]

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com. As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose information regarding the Company's products and services to public and private schools ...

Core Viewpoint - The Gross Law Firm is notifying shareholders of James Hardie Industries plc regarding a class action lawsuit due to alleged false statements and concealed adverse facts about the company's North America segment [1][3]. Group 1: Allegations - The class period for the allegations is from May 20, 2025, to August 18, 2025 [3]. - Allegations include that primary consumer demand and growth in the North America segment were deteriorating, and that overstocking was the main driver of growth, not consumer demand [3]. - There was excessive inventory at James Hardie's North America distributors as a result of these issues [3]. Group 2: Shareholder Actions - Shareholders who purchased shares during the class period are encouraged to register for the class action, with a deadline of December 23, 2025, to seek lead plaintiff status [4]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case [4]. Group 3: Law Firm Information - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5].

NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Freeport-McMoRan Inc. (NYSE: FCX). Shareholders who purchased shares of FCX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/freeport-mcmoran-inc-loss-submission-form/?id=180538&from=3 CLASS PERIOD: Februa ...

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Freeport-McMoRan Inc. regarding a class action lawsuit alleging misleading statements and safety issues at the Grasberg Block Cave mine in Indonesia [1][3]. Summary by Sections Class Action Details - The class period for the lawsuit is from February 15, 2022, to September 24, 2025 [3]. - Allegations include failure to ensure safety at the Grasberg Block Cave mine, which heightened risks of worker fatalities and regulatory, litigation, and reputational risks [3]. Shareholder Actions - Shareholders are encouraged to register for the class action by January 12, 2026, to potentially become lead plaintiffs [4]. - Registration provides access to portfolio monitoring software for status updates throughout the case [4]. Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors affected by misleading statements [5].

NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of MoonLake Immunotherapeutics (NASDAQ: MLTX). Shareholders who purchased shares of MLTX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/moonlake-loss-submission-form/?id=179485&from=3 CLASS PERIOD: March 10 ...

Company Overview - PetMed Express, Inc. is an online pet pharmacy founded in 1996, offering a wide range of medications, supplements, food, and other pet health products [3] Allegations and Stock Performance - On June 10, 2025, PetMed announced a delay in releasing its fourth-quarter and full-year 2025 financial results, leading to a stock drop of $0.47, or 11.22%, closing at $3.72 on June 11, 2025 [4] - On July 1, 2025, PetMed stated it would not file its fiscal-year 2025 Annual Report on time due to an internal review of revenue recognition, resulting in a stock decline of $0.05 per share, or 1.51%, finishing at $3.27 [5] - On November 12, 2025, PetMed reported it could not timely submit its third-quarter 2025 Form 10-Q due to an Audit Committee investigation, causing a significant stock price drop of $0.94 per share, or 32.41%, closing at $1.96 on November 13, 2025 [6] Legal Investigation - Edelson Lechtzin LLP is investigating potential violations of federal securities laws involving PetMed Express, stemming from allegations of providing misleading business information to the investing public [1]